Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobials

References

• Preliminary Foodnet data on the incidence of infection with pathogens transmitted commonly through food—10 states 2009. MMWR Morb Mortal Wkly Rep 2010; 59:418 - 422
   PubMedGoogle Scholar
• Blaser MJ, Allos BM,. Mandell GL, Bennett JE, Dolin R. Campylobacter jejuni and related species. Principles and Practice of Infectious Diseases 2005; 6th ed Philadelphia Elsevier 2548 - 2557
   Google Scholar
• Iovine NM, Pursnani S, Voldman A, Wasserman G, Blaser MJ, Weinrauch Y. Reactive nitrogen species contribute to innate host defense against Campylobacter jejuni. Infect Immun 2008; 76:986 - 993
   PubMed Web of Science ®Google Scholar
• Zilbauer M, Dorrell N, Boughan PK, Harris A, Wren BW, Klein NJ, et al. Intestinal innate immunity to Campylobacter jejuni results in induction of bactericidal human beta-defensins 2 and 3. Infect Immun 2005; 73:7281 - 7289
   PubMed Web of Science ®Google Scholar
• Butzler JP. Campylobacter, from obscurity to celebrity. Clin Microbiol Infect 2004; 10:868 - 876
   PubMed Web of Science ®Google Scholar
• Skirrow MB. Campylobacter enteritis: A “New” Disease. Br Med J 1977; 2:9 - 11
   PubMed Web of Science ®Google Scholar
• Beery JT, Hugdahl MB, Doyle MP. Colonization of gastrointestinal tracts of chicks by Campylobacter jejuni. Appl Environ Microbiol 1988; 54:2365 - 2370
   PubMed Web of Science ®Google Scholar
• Guerry P, Ewing CP, Hickey TE, Prendergast MM, Moran AP. Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacter jejuni. Infect Immun 2000; 68:6656 - 6662
   PubMed Web of Science ®Google Scholar
• Guerry P, Szymanski CM, Prendergast MM, Hickey TE, Ewing CP, Pattarini DL, et al. Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro. Infect Immun 2002; 70:787 - 793
   PubMed Web of Science ®Google Scholar
• Kanipes MI, Holder LC, Corcoran AT, Moran AP, Guerry P. A deep-rough mutant of Campylobacter jejuni 81-176 is noninvasive for intestinal epithelial cells. Infect Immun 2004; 72:2452 - 2455
   PubMed Web of Science ®Google Scholar
• Karlyshev AV, Everest P, Linton D, Cawthraw S, Newell DG, Wren BW. The Campylobacter jejuni general glycosylation system is important for attachment to human epithelial cells and in the colonization of chicks. Microbiol 2004; 150:1957 - 1964
   PubMed Web of Science ®Google Scholar
• Blaser MJ, Perez GP, Smith PF, Patton C, Tenover FC, Lastovica AJ, et al. Extraintestinal Campylobacter jejuni and Campylobacter coli infections: Host factors and strain characteristics. J Infect Dis 1986; 153:552 - 559
   PubMed Web of Science ®Google Scholar
• Dann SM, Eckmann L. Innate immune defenses in the intestinal tract. Curr Opin Gastroenterol 2007; 23:115 - 120
   PubMed Web of Science ®Google Scholar
• Diffenbach CW, Tramont EC. Mandell GL, Bennett JE, Dolin R. Innate (general or nonspecific) host defense mechanisms. Principles and Practice of Infectious Diseases 2005; 6th ed Philadelphia Elsevier 34 - 42
   Google Scholar
• Lehrer RI. Primate defensins. Nat Rev Microbiol 2004; 2:727 - 738
   PubMed Web of Science ®Google Scholar
• Scott MG, Hancock RE. Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit Rev Immunol 2000; 20:407 - 431
   PubMed Web of Science ®Google Scholar
• Weiss J. Bactericidal/Permeability-Increasing Protein (BPI) and Lipopolysaccharide-Binding Protein (LBP): Structure, function and regulation in host defence against Gram-negative bacteria. Biochem Soc Trans 2003; 31:785 - 790
   PubMed Web of Science ®Google Scholar
• Eckmann L. Innate immunity and mucosal bacterial interactions in the intestine. Curr Opin Gastroenterol 2004; 20:82 - 88
   PubMed Web of Science ®Google Scholar
• Iimura M, Gallo RL, Hase K, Miyamoto Y, Eckmann L, Kagnoff MF. Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J Immunol 2005; 174:4901 - 4907
   PubMed Web of Science ®Google Scholar
• Zanetti M, Gennaro R, Romeo D. Cathelicidins: A novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 1995; 374:1 - 5
   PubMed Web of Science ®Google Scholar
• Weiss J, Elsbach P, Olsson I, Odeberg H. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem 1978; 253:2664 - 2672
   PubMed Web of Science ®Google Scholar
• Guerry P, Szymanski CM. Campylobacter sugars sticking out. Trends Microbiol 2008; 16:428 - 435
   PubMed Web of Science ®Google Scholar
• Frank MM. Complement deficiencies. Pediatr Clin North Am 2000; 47:1339 - 1354
   PubMed Web of Science ®Google Scholar
• Naito M, Frirdich E, Fields JA, Pryjma M, Li J, Cameron A, et al. Effects of sequential Campylobacter jejuni 81-176 lipooligosaccharide core truncations on biofilm formation, stress survival and pathogenesis. J Bacteriol 2010; 192:2182 - 2192
   PubMed Web of Science ®Google Scholar
• Bacon DJ, Szymanski CM, Burr DH, Silver RP, Alm RA, Guerry P. A phase-variable capsule is involved in virulence of Campylobacter jejuni 81-176. Mol Microbiol 2001; 40:769 - 777
   PubMed Web of Science ®Google Scholar
• Hani EK, Chan VL. Expression and characterization of Campylobacter jejuni benzoylglycine amidohydrolase (hippuricase) gene in Escherichia coli. J Bacteriol 1995; 177:2396 - 2402
   PubMed Web of Science ®Google Scholar
• Slater ER, Owen RJ. Restriction fragment length polymorphism analysis shows that the hippuricase gene of Campylobacter jejuni is highly conserved. Lett Appl Microbiol 1997; 25:274 - 278
   PubMed Web of Science ®Google Scholar
• Karlyshev AV, Wren BW. Development and application of an insertional system for gene delivery and expression in Campylobacter jejuni. Appl Environ Microbiol 2005; 71:4004 - 4013
   PubMed Web of Science ®Google Scholar
• Yao R, Burr DH, Guerry P. CheY-mediated modulation of Campylobacter jejuni virulence. Mol Microbiol 1997; 23:1021 - 1031
   PubMed Web of Science ®Google Scholar
• Yao R, Guerry P. Molecular cloning and site-specific mutagenesis of a gene involved in arylsulfatase production in Campylobacter jejuni. J Bacteriol 1996; 178:3335 - 3338
   PubMed Web of Science ®Google Scholar
• Karlyshev AV, Linton D, Gregson NA, Lastovica AJ, Wren BW. Genetic and biochemical evidence of a Campylobacter jejuni capsular polysaccharide that accounts for penner serotype specificity. Mol Microbiol 2000; 35:529 - 541
   PubMed Web of Science ®Google Scholar
• Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, et al. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem 2002; 277:327 - 337
   PubMed Web of Science ®Google Scholar
• Parker CT, Gilbert M, Yuki N, Endtz HP, Mandrell RE. Characterization of lipooligosaccharide-biosynthetic loci of Campylobacter jejuni reveals new lipooligosaccharide classes: Evidence of mosaic organizations. J Bacteriol 2008; 190:5681 - 5689
   PubMed Web of Science ®Google Scholar
• St. Michael F, Szymanski CM, Li J, Chan KH, Khieu NH, Larocque S, et al. The structures of the lipooligosaccharide and capsule polysaccharide of Campylobacter jejuni genome sequenced strain NCTC 11168. Eur J Biochem 2002; 269:5119 - 5136
   PubMedGoogle Scholar
• Oldfield NJ, Moran AP, Millar LA, Prendergast MM, Ketley JM. Characterization of the Campylobacter jejuni heptosyltransferase II gene, waaf, provides genetic evidence that extracellular polysaccharide is lipid A core independent. J Bacteriol 2002; 184:2100 - 2107
   PubMed Web of Science ®Google Scholar
• Ganz T. Defensins: Antimicrobial peptides of vertebrates. C R Biol 2004; 327:539 - 549
   PubMed Web of Science ®Google Scholar
• Cross AS, Kim KS, Wright DC, Sadoff JC, Gemski P. Role of lipopolysaccharide and capsule in the serum resistance of bacteremic strains of Escherichia coli. J Infect Dis 1986; 154:497 - 503
   PubMed Web of Science ®Google Scholar
• Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 2003; 422:522 - 526
   PubMed Web of Science ®Google Scholar
• Ayabe T, Satchell DP, Wilson CL, Parks WC, Selsted ME, Ouellette AJ. Secretion of microbicidal alpha-defensins by intestinal paneth cells in response to bacteria. Nat Immunol 2000; 1:113 - 118
   PubMed Web of Science ®Google Scholar
• Ouellette AJ. Iv. Paneth cell antimicrobial peptides and the biology of the mucosal barrier. Am J Physiol 1999; 277:257 - 261
   Google Scholar
• Cowland JB, Johnsen AH, Borregaard N. hCap-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules. FEBS Lett 1995; 368:173 - 176
   PubMed Web of Science ®Google Scholar
• Xiao Y, Cai Y, Bommineni YR, Fernando SC, Prakash O, Gilliland SE, et al. Identification and functional characterization of three chicken cathelicidins with potent antimicrobial activity. J Biol Chem 2006; 281:2858 - 2867
   PubMed Web of Science ®Google Scholar
• Jones A, Georg M, Maudsdotter L, Jonsson AB. Endotoxin, capsule and bacterial attachment contribute to Neisseria meningitidis resistance to the human antimicrobial peptide LL-37. J Bacteriol 2009; 191:3861 - 3868
   PubMed Web of Science ®Google Scholar
• Hancock RE, Diamond G. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol 2000; 8:402 - 410
   PubMed Web of Science ®Google Scholar
• Weiss J, Elsbach P, Shu C, Castillo J, Grinna L, Horwitz A, et al. Human Bactericidal/Permeability-Increasing Protein and a recombinant NH2-terminal fragment cause killing of serum-resistant Gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. J Clin Invest 1992; 90:1122 - 1130
   PubMed Web of Science ®Google Scholar
• Iovine NM, Elsbach P, Weiss J. An opsonic function of the neutrophil Bactericidal/Permeability-Increasing Protein depends on both its N- and C-terminal domains. Proc Natl Acad Sci USA 1997; 94:10973 - 10978
   PubMed Web of Science ®Google Scholar
• Weiss J, Beckerdite-Quagliata S, Elsbach P. Resistance of Gram-negative bacteria to purified bactericidal leukocyte proteins: Relation to binding and bacterial lipopolysaccharide structure. J Clin Invest 1980; 65:619 - 628
   PubMed Web of Science ®Google Scholar
• Weiss J, Hutzler M, Kao L. Environmental modulation of lipopolysaccharide chain length alters the sensitivity of Escherichia coli to the neutrophil Bactericidal/Permeability-Increasing Protein. Infect Immun 1986; 51:594 - 599
   PubMed Web of Science ®Google Scholar
• Wassenaar TM, Fry BN, van der Zeijst BA. Genetic manipulation of campylobacter: Evaluation of natural transformation and electro-transformation. Gene 1993; 132:131 - 135
   PubMed Web of Science ®Google Scholar
• Miller JF, Dower WJ, Tompkins LS. High-voltage electroporation of bacteria: Genetic transformation of Campylobacter jejuni with plasmid DNA. Proc Natl Acad Sci USA 1988; 85:856 - 860
   PubMed Web of Science ®Google Scholar
• Labigne-Roussel A, Harel J, Tompkins L. Gene transfer from Escherichia coli to Campylobacter species: Development of shuttle vectors for genetic analysis of Campylobacter jejuni. J Bacteriol 1987; 169:5320 - 5323
   PubMed Web of Science ®Google Scholar
• Morrison DC, Jacobs DM. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochem 1976; 13:813 - 818
   PubMedGoogle Scholar
• Johnson RJ, Nolan C, Wang SP, Shelton WR, Blaser MJ. Persistent Campylobacter jejuni infection in an immunocompromised patient. Ann Intern Med 1984; 100:832 - 834
   PubMed Web of Science ®Google Scholar
• Lekstrom-Himes JA, Gallin JI. Immunodeficiency diseases caused by defects in phagocytes. N Engl J Med 2000; 343:1703 - 1714
   PubMed Web of Science ®Google Scholar
• Gazzano-Santoro H, Parent JB, Grinna L, Horwitz A, Parsons T, Theofan G, et al. High-affinity binding of the Bactericidal/Permeability-Increasing Protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun 1992; 60:4754 - 4761
   PubMed Web of Science ®Google Scholar
• Bokarewa MI, Jin T, Tarkowski A. Intraarticular release and accumulation of defensins and Bactericidal/Permeability-Increasing Protein in patients with rheumatoid arthritis. J Rheumatol 2003; 30:1719 - 1724
   PubMed Web of Science ®Google Scholar
• Opal SM, Palardy JE, Marra MN, Fisher CJ Jr, McKelligon BM, Scott RW. Relative concentrations of endotoxin-binding proteins in body fluids during infection. Lancet 1994; 344:429 - 431
   PubMed Web of Science ®Google Scholar
• Weinrauch Y, Foreman A, Shu C, Zarember K, Levy O, Elsbach P, et al. Extracellular accumulation of potently microbicidal Bactericidal/Permeability-Increasing Protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate. J Clin Invest 1995; 95:1916 - 1924
   PubMed Web of Science ®Google Scholar
• Moffitt MC, Frank MM. Complement resistance in microbes. Springer Semin Immunopathol 1994; 15:327 - 344
   PubMed Web of Science ®Google Scholar
• McNally DJ, Lamoureux MP, Karlyshev AV, Fiori LM, Li J, Thacker G, et al. Commonality and biosynthesis of the o-methyl phosphoramidate capsule modification in Campylobacter jejuni. J Biol Chem 2007; 282:28566 - 28576
   PubMed Web of Science ®Google Scholar
• McNally DJ, Jarrell HC, Khieu NH, Li J, Vinogradov E, Whitfield DM, et al. The HS:19 serostrain of Campylobacter jejuni has a hyaluronic acid-type capsular polysaccharide with a nonstoichiometric sorbose branch and o-methyl phosphoramidate group. FEBS J 2006; 273:3975 - 3989
   PubMed Web of Science ®Google Scholar
• Takata T, Aras R, Tavakoli D, Ando T, Olivares AZ, Blaser MJ. Phenotypic and genotypic variation in methylases involved in type II restriction-modification systems in Helicobacter pylori. Nucleic Acids Res 2002; 30:2444 - 2452
   PubMed Web of Science ®Google Scholar
• Karlyshev AV, Wren BW. Detection and initial characterization of novel capsular polysaccharide among diverse Campylobacter jejuni strains using Alcian Blue dye. J Clin Microbiol 2001; 39:279 - 284
   PubMed Web of Science ®Google Scholar
• DeCross AJ, Marshall BJ, McCallum RW, Hoffman SR, Barrett LJ, Guerrant RL. Metronidazole susceptibility testing for Helicobacter pylori: Comparison of disk, broth and agar dilution methods and their clinical relevance. J Clin Microbiol 1993; 31:1971 - 1974
   PubMed Web of Science ®Google Scholar
• Blaser MJ, Smith PF, Kohler PF. Susceptibility of Campylobacter isolates to the bactericidal activity of human serum. J Infect Dis 1985; 151:227 - 235
   PubMed Web of Science ®Google Scholar
• Blaser MJ, Duncan DJ. Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay. Infect Immun 1984; 44:292 - 298
   PubMed Web of Science ®Google Scholar
• Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, et al. Clustal W and clustal X version 2.0. Bioinformatics 2007; 23:2947 - 2948
   PubMed Web of Science ®Google Scholar
• Parkhill J, Wren BW, Mungall K, Ketley JM, Churcher C, Basham D, et al. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 2000; 403:665 - 668
   PubMed Web of Science ®Google Scholar
• Kanipes MI, Tan X, Akelaitis A, Li J, Rockabrand D, Guerry P, et al. Genetic analysis of lipooligosaccharide core biosynthesis in Campylobacter jejuni 81-176. J Bacteriol 2008; 190:1568 - 1574
   PubMed Web of Science ®Google Scholar
• Gilbert M, Brisson JR, Karwaski MF, Michniewicz J, Cunningham AM, Wu Y, et al. Biosynthesis of ganglioside mimics in Campylobacter jejuni OH4384. Identification of the glycosyltransferase genes, enzymatic synthesis of model compounds and characterization of nanomole amounts by 600 mhz (1)h and (13)c NMR analysis. J Biol Chem 2000; 275:3896 - 3906
   PubMed Web of Science ®Google Scholar
• Korlath JA, Osterholm MT, Judy LA, Forfang JC, Robinson RA. A point-source outbreak of campylobacteriosis associated with consumption of raw milk. J Infect Dis 1985; 152:592 - 596
   PubMed Web of Science ®Google Scholar
• Tummuru MK, Blaser MJ. Characterization of the Campylobacter fetus sapA promoter: Evidence that the sapA promoter is deleted in spontaneous mutant strains. J Bacteriol 1992; 174:5916 - 5922
   PubMed Web of Science ®Google Scholar